Carladenise Armbrister Edwards is Director of CLOVER HEALTH INVESTMENTS, CORP. . Currently has a direct ownership of 412,252 shares of CLOV, which is worth approximately $1.1 Million. The most recent transaction as insider was on Jan 03, 2024, when has been sold 206,185 shares (Class A Common Stock) at a price of $0.97 per share, resulting in proceeds of $199,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 412K
0% 3M change
100.06% 12M change
Total Value Held $1.1 Million

Carladenise Armbrister Edwards Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2024
BUY
Grant, award, or other acquisition
$199,999 $0.97 p/Share
206,185 Added 33.34%
412,252 Class A Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
176,991 Added 46.2%
206,067 Class A Common Stock
Sep 22 2022
BUY
Grant, award, or other acquisition
-
20,271 Added 41.08%
29,076 Class A Common Stock
Jul 22 2022
BUY
Grant, award, or other acquisition
-
8,805 Added 50.0%
8,805 Class A Common Stock
CAE

Carladenise Armbrister Edwards

Director
Franklin, TN

Track Institutional and Insider Activities on CLOV

Follow CLOVER HEALTH INVESTMENTS, CORP. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLOV shares.

Notify only if

Insider Trading

Get notified when an Clover Health Investments, Corp. insider buys or sells CLOV shares.

Notify only if

News

Receive news related to CLOVER HEALTH INVESTMENTS, CORP.

Track Activities on CLOV